收藏切换
Clinical research progress of Loncastuximab tesirine-lpyl
收藏切换
Lu WANG1, Yan REN1, Ziwen DING1, Jingyan ZHANG2, Yiyun YUAN2, Junlong WANG2, *, Na NI1, *
World Clinical Drug | 2022, 43(2) : 200 - 204
Less
收藏切换
World Clinical Drug | 2022, 43(2): 200-204
• Review •
Clinical research progress of Loncastuximab tesirine-lpyl
Full
Lu WANG1, Yan REN1, Ziwen DING1, Jingyan ZHANG2, Yiyun YUAN2, Junlong WANG2, *, Na NI1, *
Affiliations
  • 1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China
Published: 2022-02-10 doi: 10.13683/j.wph.2022.02.017
Outline
收藏切换

Loncastuximab tesirine-lpyl was approved by FDA on April 23, 2021. It is the first approved CD19 antibody coupled drug targeting pyrrolobenzodiazepine (PBD) dimer for the treatment of adult patients with recurrent or refractory large B-cell lymphoma who have received two or more systemic therapies. This paper mainly reviewed the clinical research progress of loncastuximab tesirine-lpyl in B-cell-derived malignant tumors, in order to provide a new reference for the clinical treatment of adult patients with recurrent or refractory large B-cell lymphoma.

CD19  /  loncastuximab tesirine-lpyl  /  ADC  /  large B-cell lymphoma
汪璐, 任燕, 丁子文, 张婧妍, 袁宜耘, 王俊龙, 倪娜. Loncastuximab tesirine-lpyl的临床研究进展. 世界临床药物, 2022 , 43 (2) : 200 -204 . DOI: 10.13683/j.wph.2022.02.017
Lu WANG, Yan REN, Ziwen DING, Jingyan ZHANG, Yiyun YUAN, Junlong WANG, Na NI. Clinical research progress of Loncastuximab tesirine-lpyl[J]. World Clinical Drug, 2022 , 43 (2) : 200 -204 . DOI: 10.13683/j.wph.2022.02.017
Year 2022 volume 43 Issue 2
13
4
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.02.017
  • Receive Date:2021-09-22
  • Online Date:2026-11-19
  • Published:2022-02-10
Article Data
Affiliations
History
  • Received:2021-09-22
Affiliations
    1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
    2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.02.017
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT